The Impact of Demographic Changes on Blood Donation and Transfusion Demand, Implications of a Population Based Longitudinal Study
Special guest speaker Dr. Andreas Greinacher University Hospital Greifswald, Germany Head of the Institute of Immunology and Transfusion Medicine Objectives 1. To understand the association between demographic changes and blood donation numbers To become aware that the baby boom generation who is
Nov 9 12:00 pm | 585 University Avenue - UHN MaRS Building - 9th floor Room 9005
2nd Annual ACB Organ Health Summit
Better Health, Better Life! Welcome to the 2nd Annual ACB Organ Health Summit! Join us at Toronto General Hospital- MaRS Building for a day filled with informative sessions about healthy eating, mental health and racism in health care, along with an interactive panel about organ donation. Learn from
Nov 13 12:00 pm | Virtual
CHEER Webinar Series: Integrating the patient perspective in pediatric clinical care through the implementation of Voxe: An electronic patient-reported outcome measure platform with Samantha Anthony and Sarah Pol
CHEER Webinar Series 2025-2026 Integrating the patient perspective in pediatric clinical care through the implementation of Voxe: An electronic patient-reported outcome measure platform with Samantha Anthony and Sarah Pol Date: November 13, 2025 Time: 12:00 - 1:00pm EST Join us for an insightful
Nov 6 11:00 am | Toronto/Virtual
Genomics Programme in England: Real World Validation and Reporting
Presented by Dr. Shane Grimsley Clinical Scientist Blood Group Reference Laboratory at NHS Blood and Transplant Dr. Nicholas Gleadall Assistant Professor in Clinical Genomics of Transfusion and Transplant University of Cambridge Learning Objectives 1. Theory of predicting phenotype from genotype. 2
Nov 18 12:00 pm | Toronto/Virtual
Topic: HLA Testing
Presented by Dr. Akash Gupta MD, FRCPC Department of Laboratory Medicine & Pathobiology Learning objectives TBA Note: The session is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada
Nov 4 12:00 pm | Toronto/Virtual
Topic: A Social History of Transfusion Medicine
Presented by Dr. Jean Wang MD, PhD, FRCPC Clinician Scientist, Princess Margaret Cancer Centre Learning objectives 1. Discover the challenges of blood group classification prior to WWII. 2. Discover how blood donor services supported the military during wartime. 3. See below for relevant preparatory
Nov 14 9:30 am | Virtual
Blood Matters 2025
Blood Matters 2025 is being offered virtually on Friday, November 14, 2025 from 9:30am to 3:15pm AT. This free, transfusion-focused education day is hosted by the Nova Scotia Provincial Blood Coordinating Team. Learning objectives After participating in this session, attendees will be able to
Oct 16 12:00 pm | Virtual
Qualitative methods and transfusion medicine
The Canadian Transfusion Trials Group (CTTG) is a pioneering national initiative designed to promote collaboration and excellence in Transfusion Medicine research. CTTG, led by co-directors Drs. Donald Arnold and Jeannie Callum, represents a paradigm shift in transfusion medicine research. CTTG
ICTMG knowledge mobilization activities promote appropriate use of albumin
Albumin is the most abundant protein found in human plasma. Intravenous albumin is a therapeutic product used in a variety of clinical settings for both pediatric and adult patients. As with any blood product, its use should be carefully stewarded to optimize patient outcomes, preserve blood bank resources, and minimize potential harms. In 2024, the International Collaboration for Transfusion Medicine Guidelines (ICTMG) – a collaborative of expert volunteers around the globe whose secretariat is hosted by Canadian Blood Services – published a new clinical guideline offering evidence-based
October 9, 2025
Nov 7 8:00 am | Virtual
The McMaster Immune Thrombocytopenia (ITP) Summit 2025
McMaster University presents the Immune Thrombocytopenia (ITP) Summit 2025, a virtual CPD conference designed to enhance participants’ understanding of the underlying mechanisms and evolving treatment approaches for Immune Thrombocytopenia (ITP).The target audience for this event includes
